State Street SPDR S&P Biotech ETF (XBI) es una empresa que cotiza en bolsa en el Servicios Financieros sector, operando dentro de la Asset Management industria. La empresa tiene su sede en Boston, MA, United States.
XBI tiene fecha de IPO 2006-02-06, cotiza en el NYSE, una capitalización de mercado de $7.69B.
State Street SPDR S&P Biotech ETF (XBI) is an exchange-traded fund designed to track the performance of the S&P Biotechnology Select Industry Index. The fund invests at least 80% of its total assets in securities that comprise the index, using a sampling strategy to replicate index performance. XBI provides exposure to the biotechnology segment of the S&P Total Market Index, offering investors a diversified way to gain access to the U.S. biotech industry.